AccScience Publishing / MI / Online First / DOI: 10.36922/mi.3599
Submit to MI
Cite this article
61
Download
751
Views
Journal Browser
Volume | Year
Issue
Search
Forthcoming Issue
Current Issue
View All
News and Announcements
View All
LETTER TO EDITOR

The re-emergence of Mycoplasma pneumoniae in the post-COVID-19 era: Challenges in diagnosis and treatment in low- and middle-income countries

Mohamad S. Hakim1*
Show Less
1 Postgraduate School of Molecular Medicine, Erasmus MC-University Medical Center, Rotterdam, the Netherlands
MI 2024, 1(1), 121–124; https://doi.org/10.36922/mi.3599
Submitted: 7 May 2024 | Accepted: 28 May 2024 | Published: 4 June 2024
© 2024 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Download PDF
Cite
XML
Conflict of interest
The author declares that he has no competing interests.
References
  1. Meyer Sauteur PM, Unger WW, Nadal D, Berger C, Vink C, van Rossum AM. Infection with and carriage of Mycoplasma pneumoniae in children. Front Microbiol. 2016;7:329. doi: 10.3389/fmicb.2016.00329

 

  1. Meyer Sauteur PM, Beeton ML, Uldum SA, et al. Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: Results of a global survey, 2017 to 2021. Euro Surveill. 2022;27(19):2100746. doi: 10.2807/1560-7917.ES.2022.27.19.2100746

 

  1. Meyer Sauteur PM, Chalker VJ, Berger C, Nir-Paz R, Beeton ML, ESGMAC and the ESGMAC-MyCOVID Study Group. Mycoplasma pneumoniae beyond the COVID-19 pandemic: Where is it? Lancet Microbe. 2022;3(12):e897. doi: 10.1016/S2666-5247(22)00190-2

 

  1. Meyer Sauteur PM, Beeton ML, ESGMAC the ESGMAC MAPS Study Group. Mycoplasma pneumoniae: Gone forever? Lancet Microbe. 2023;4(10):e763. doi: 10.1016/S2666-5247(23)00182-9

 

  1. Barnes M, Youngkin E, Zipprich J, et al. Notes from the field: Increase in pediatric invasive Group A Streptococcus infections - Colorado and Minnesota, October-December 2022. MMWR Morb Mortal Wkly Rep. 2023;72(10):265-267. doi: 10.15585/mmwr.mm7210a4

 

  1. Meyer Sauteur PM, Beeton ML, European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) Study Group. Mycoplasma pneumoniae: Delayed re-emergence after COVID-19 pandemic restrictions. Lancet Microbe. 2023;5(2):e100-e101. doi: 10.1016/S2666-5247(23)00344-0

 

  1. WHO. Upsurge of Respiratory Illnesses among Children- Northern China; 2023. Available from: https://www.who.int/ emergencies/disease-outbreak-news/item/2023-DON494 [Last accessed on 2023 Dec 13].

 

  1. Bolluyt DC, Euser SM, Souverein D, et al. Increased incidence of Mycoplasma pneumoniae infections and hospital admissions in the Netherlands, November to December 2023. Euro Surveill. 2024;29(4):2300724. doi: 10.2807/1560-7917.ES.2024.29.4.2300724

 

  1. Nordholm AC, Soborg B, Jokelainen P, et al. Mycoplasma pneumoniae epidemic in Denmark, October to December, 2023. Euro Surveill. 2024;29(2):2300707. doi: 10.2807/1560-7917.ES.2024.29.2.2300707

 

  1. Larcher R, Boudet A, Roger C, Villa F, Loubet P. Mycoplasma pneumoniae is back! Is it the next pandemic? Anaesth Crit Care Pain Med. 2023;43(1):101338. doi: 10.1016/j.accpm.2023.101338

 

  1. Edens C, Clopper BR, DeVies J, et al. Notes from the field: Reemergence of Mycoplasma pneumoniae infections in children and adolescents after the COVID-19 pandemic, United States, 2018-2024. MMWR Morb Mortal Wkly Rep. 2024;73(7):149-151. doi: 10.15585/mmwr.mm7307a3

 

  1. Ministry of Health, Indonesia. Mycoplasma pneumoniae Ditemukan di Indonesia (Mycoplasma pneumoniae is Found in Indonesia); 2023 Available from: https://sehatnegeriku. kemke s . go. i d / baca/umum/20231206/1044400/ mycoplasma-pneumoniae-ditemukan-di-indonesia [Last accessed on 2023 Dec 13].

 

  1. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008;32(6):956-973. doi: 10.1111/j.1574-6976.2008.00129.x

 

  1. Sreenath K, Kabra SK, Dey AB, et al. Mycoplasma pneumoniae among hospitalized patients with acute respiratory tract infections in an Indian tertiary care hospital: An underreported health problem. Microbiol Spectr. 2022;10(4):e0158922. doi: 10.1128/spectrum.01589-22

 

  1. Suzuki Y, Itagaki T, Seto J, et al. Community outbreak of macrolide-resistant Mycoplasma pneumoniae in Yamagata, Japan in 2009. Pediatr Infect Dis J. 2013;32(3):237-240. doi: 10.1097/INF.0b013e31827aa7bd

 

  1. Gardiner SJ, Gavranich JB, Chang AB. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Cochrane Database Syst Rev. 2015;1(1):CD004875. doi: 10.1002/14651858.CD004875.pub5

 

  1. Spuesens EB, Fraaij PL, Visser EG, et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: An observational study. PLoS Med. 2013;10(5):e1001444. doi: 10.1371/journal.pmed.1001444

 

  1. Lokida D, Farida H, Triasih R, et al. Epidemiology of community-acquired pneumonia among hospitalised children in Indonesia: A multicentre, prospective study. BMJ Open. 2022;12(6):e057957. doi: 10.1136/bmjopen-2021-057957

 

  1. Yun KW. Community-acquired pneumonia in children: An updated perspectives on its etiology, diagnosis, and treatment. Clin Exp Pediatr. 2024;67(2):80-89. doi: 10.3345/cep.2022.01452

 

  1. Xu C, Deng H, Zhang J, et al. Mutations in domain V of Mycoplasma pneumoniae 23S rRNA and clinical characteristics of pediatric M. pneumoniae pneumonia in Nanjing, China. J Int Med Res. 2021; 49(6):3000605211016376. doi: 10.1177/03000605211016376

 

  1. Loconsole D, De Robertis AL, Sallustio A, et al. Update on the epidemiology of macrolide-resistant Mycoplasma pneumoniae in Europe: A systematic review. Infect Dis Rep. 2021;13(3):811-820. doi: 10.3390/idr13030073

 

  1. Jiang TT, Sun L, Wang TY, et al. The clinical significance of macrolide resistance in pediatric Mycoplasma pneumoniae infection during COVID-19 pandemic. Front Cell Infect Microbiol. 2023;13:1181402. doi: 10.3389/fcimb.2023.1181402

 

  1. Lin L, Zhang R, Zhang Z, et al. Clinical value of metagenomics next-generation sequencing in antibiotic resistance of a patient with severe refractory Mycoplasma pneumoniae pneumonia: A case report. Infect Drug Resist. 2023;16:4593-4597. doi: 10.2147/IDR.S419873
Share
Back to top
Microbes & Immunity, Electronic ISSN: 3029-2883 Print ISSN: 3041-0886, Published by AccScience Publishing
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here
Accept